Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): results from the CanACT study.
about
TNF inhibitor therapy for rheumatoid arthritisSystemic adalimumab induces peripheral corneal infiltrates: a case report.The efficacy and safety of subcutaneous clazakizumab in patients with moderate-to-severe rheumatoid arthritis and an inadequate response to methotrexate: results from a multinational, phase IIb, randomized, double-blind, placebo/active-controlled, d
P2860
Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): results from the CanACT study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Safety and effectiveness of ad ...... results from the CanACT study.
@ast
Safety and effectiveness of ad ...... results from the CanACT study.
@en
Safety and effectiveness of ad ...... atment of rheumatoid arthritis
@nl
type
label
Safety and effectiveness of ad ...... results from the CanACT study.
@ast
Safety and effectiveness of ad ...... results from the CanACT study.
@en
Safety and effectiveness of ad ...... atment of rheumatoid arthritis
@nl
prefLabel
Safety and effectiveness of ad ...... results from the CanACT study.
@ast
Safety and effectiveness of ad ...... results from the CanACT study.
@en
Safety and effectiveness of ad ...... atment of rheumatoid arthritis
@nl
P2093
P2860
P356
P1476
Safety and effectiveness of ad ...... results from the CanACT study.
@en
P2093
Alfred Cividino
Benoît Guérette
Boulos Haraoui
Edward C Keystone
Jacqueline Stewart
P2860
P2888
P356
10.1186/1471-2474-12-261
P577
2011-11-17T00:00:00Z
P5875
P6179
1000710106